HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment

scientific article published on 29 December 2019

HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1136/BMJOPEN-2019-033059
P932PMC publication ID6937034
P698PubMed publication ID31888933

P50authorAlicia JenkinsQ63481321
David O'NealQ87947749
Emma S ScottQ92334102
P2093author name stringAnandwardhan A Hardikar
Rachel T McGrath
Andrzej S Januszewski
Gregory Fulcher
Daniel Calandro
P2860cites workContinuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitusQ24240609
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research GroupQ27861088
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 DiabetesQ30274891
Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at HomeQ30276766
A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications TrialQ31164826
Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trialQ33873080
HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetesQ34546548
A1C variability as an independent risk factor for microalbuminuria in young people with type 1 diabetesQ34718250
HbA1c variability as an independent risk factor for diabetic retinopathy in type 1 diabetes: a German/Austrian multicenter analysis on 35,891 patientsQ35114974
Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational studyQ35765550
Insulin Pump Therapy Is Associated with Lower Rates of Retinopathy and Peripheral Nerve AbnormalityQ35981134
Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetesQ36297813
Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 studyQ36417410
Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR StudyQ37280510
A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetesQ37400773
Systematic review of the Hawthorne effect: new concepts are needed to study research participation effectsQ37671448
Healthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in AustraliaQ38265052
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.Q38381848
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical TrialQ38381853
Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis.Q38647077
Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With Type 1 Diabetes.Q39760755
Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproductionQ40353553
High hemoglobin A1c variability is associated with early risk of microalbuminuria in children with T1D.Q40531970
Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow-up studyQ41431685
Continuous subcutaneous insulin infusion is better than multiple daily insulin injections in reducing glucose variability only in type 1 diabetes with good metabolic controlQ43052147
Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetesQ43441184
Short-term peaks in glucose promote renal fibrogenesis independently of total glucose exposure.Q44869345
International Consensus on Use of Continuous Glucose Monitoring.Q45073594
A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.Q46149736
Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetesQ46667179
Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patientsQ46734168
A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE TrialQ47387128
Metabolic control and its variability are major risk factors for microalbuminuria in children with type 1 diabetesQ48866435
Vascular function and glucose variability improve transiently following initiation of continuous subcutaneous insulin infusion in children with type 1 diabetesQ49168090
Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.Q51246622
Effect of Sensor-Augmented Pump Treatment Versus Multiple Daily Injections on Albuminuria: A 1-Year Randomized Study.Q51713216
Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort studyQ88412797
Short-term glucose variability in adults with Type 1 diabetes does not differ between insulin pump and multiple daily injection users - a masked continuous glucose monitoring study in clinical practiceQ89224061
Variability in Glycated Hemoglobin and Risk of Poor Outcomes Among People With Type 2 Diabetes in a Large Primary Care Cohort StudyQ90465934
P433issue12
P921main subjecttype-1 diabetesQ124407
P304page(s)e033059
P577publication date2019-12-29
P1433published inBMJ OpenQ17003470
P1476titleHbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment
P478volume9

Search more.